Manager 22Feb12: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 4: Line 4:
** making reports/detailed documents available on the wiki  
** making reports/detailed documents available on the wiki  
** composition of the PAINT training groups
** composition of the PAINT training groups
** what does 'complete' annotation mean? Would it refer to the set of annotations to a gene product, or the contents of a single annotation line? (Emily)
** CAF usage: optional? (Emily)
** CAF usage: optional? (Emily)
** 'not a volunteer consortium' agenda text concern (Emily)
** 'not a volunteer consortium' agenda text concern (Emily)
** clarification of specific agenda topics (e.g. Claire & Rolf's presentaion of additional gene function information - day 2) (Emily)
** clarification of specific agenda topics (e.g. Claire & Rolf's presentaion of additional gene function information - day 2) (Emily)
** clarification of goals finalized on day 3.
** clarification of goals finalized on day 3. (Emily)


** Should Kimberly be provided with results from the questionnaire and the annotation activities document - so she can respond to some of these needs in her presentation? (Emily)


* Biology of Genomes CSHL meeting (http://meetings.cshl.edu/meetings/genome12.shtml)
* Biology of Genomes CSHL meeting (http://meetings.cshl.edu/meetings/genome12.shtml)
** Anybody planning to go?
** Anybody planning to go?


** Emily's meeting with Sarah Burge, Rfam - interest in GO annotation of ncRNAs.
** Summary Emily's meeting with Sarah Burge, Rfam - interest in GO annotation of ncRNAs.

Revision as of 08:32, 22 February 2012

Discussion on the agenda

  • GOC meeting preparation
    • details on presentations (how short etc)
    • making reports/detailed documents available on the wiki
    • composition of the PAINT training groups
    • what does 'complete' annotation mean? Would it refer to the set of annotations to a gene product, or the contents of a single annotation line? (Emily)
    • CAF usage: optional? (Emily)
    • 'not a volunteer consortium' agenda text concern (Emily)
    • clarification of specific agenda topics (e.g. Claire & Rolf's presentaion of additional gene function information - day 2) (Emily)
    • clarification of goals finalized on day 3. (Emily)
    • Should Kimberly be provided with results from the questionnaire and the annotation activities document - so she can respond to some of these needs in her presentation? (Emily)
    • Summary Emily's meeting with Sarah Burge, Rfam - interest in GO annotation of ncRNAs.